# A Study of TAK-662 for Japanese Patients With Congenital Protein C Deficiency

> **NCT04984889** · PHASE1,PHASE2 · COMPLETED · sponsor: **Takeda** · enrollment: 5 (actual)

## Conditions studied

- Congenital Protein C Deficiency

## Interventions

- **DRUG:** TAK-662

## Key facts

- **NCT ID:** NCT04984889
- **Lead sponsor:** Takeda
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-09-07
- **Primary completion:** 2022-03-29
- **Final completion:** 2024-10-31
- **Target enrollment:** 5 (ACTUAL)
- **Last updated:** 2025-05-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04984889

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04984889, "A Study of TAK-662 for Japanese Patients With Congenital Protein C Deficiency". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT04984889. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*